{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:15:51Z","timestamp":1791350151714,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,10,26]],"date-time":"2012-10-26T00:00:00Z","timestamp":1351209600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1007\/s00259-012-2261-2","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T10:14:21Z","timestamp":1351160061000},"page":"125-132","source":"Crossref","is-referenced-by-count":101,"title":["Comparison of the binding characteristics of [18F]THK-523 and other amyloid imaging tracers to Alzheimer\u2019s disease pathology"],"prefix":"10.1007","volume":"40","author":[{"given":"Ryuichi","family":"Harada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Furumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Tago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Arai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitsuka","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,10,26]]},"reference":[{"key":"2261_CR1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","volume":"6","author":"A Nordberg","year":"2010","unstructured":"Nordberg A, Rinne JO, Kadir A, Langstrom B. The use of PET in Alzheimer disease. Nat Rev Neurol. 2010;6:78\u201387. doi: 10.1038\/nrneurol.2009.217 .","journal-title":"Nat Rev Neurol"},{"key":"2261_CR2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.2174\/156802607782507402","volume":"7","author":"S Furumoto","year":"2007","unstructured":"Furumoto S, Okamura N, Iwata R, Yanai K, Arai H, Kudo Y. Recent advances in the development of amyloid imaging agents. Curr Top Med Chem. 2007;7:1773\u201389.","journal-title":"Curr Top Med Chem"},{"key":"2261_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","volume":"10","author":"K Shoghi-Jadid","year":"2002","unstructured":"Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry. 2002;10:24\u201335.","journal-title":"Am J Geriatr Psychiatry"},{"key":"2261_CR4","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1021\/jm030026b","volume":"46","author":"CA Mathis","year":"2003","unstructured":"Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J Med Chem. 2003;46:2740\u201354. doi: 10.1021\/jm030026b .","journal-title":"J Med Chem"},{"key":"2261_CR5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","volume":"55","author":"WE Klunk","year":"2004","unstructured":"Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306\u201319. doi: 10.1002\/ana.20009 .","journal-title":"Ann Neurol"},{"key":"2261_CR6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2967\/jnumed.106.037556","volume":"48","author":"Y Kudo","year":"2007","unstructured":"Kudo Y, Okamura N, Furumoto S, Tashiro M, Furukawa K, Maruyama M, et al. 2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6- (2-[fluoro]ethoxy)benzoxazole: a novel PET agent for in vivo detection of dense amyloid plaques in Alzheimer's disease patients. J Nucl Med. 2007;48:553\u201361.","journal-title":"J Nucl Med"},{"key":"2261_CR7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","volume":"131","author":"MD Ikonomovic","year":"2008","unstructured":"Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain. 2008;131:1630\u201345. doi: 10.1093\/brain\/awn016 .","journal-title":"Brain"},{"key":"2261_CR8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:280\u201392. doi: 10.1016\/j.jalz.2011.03.003 .","journal-title":"Alzheimers Dement"},{"key":"2261_CR9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","volume":"9","author":"CR Jack Jr","year":"2010","unstructured":"Jack Jr CR, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119\u201328. doi: 10.1016\/S1474-4422(09)70299-6 .","journal-title":"Lancet Neurol"},{"key":"2261_CR10","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain. 2007;130:2837\u201344. doi: 10.1093\/brain\/awm238 .","journal-title":"Brain"},{"key":"2261_CR11","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1523\/JNEUROSCI.1738-05.2005","volume":"25","author":"N Okamura","year":"2005","unstructured":"Okamura N, Suemoto T, Furumoto S, Suzuki M, Shimadzu H, Akatsu H, et al. Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer's disease. J Neurosci. 2005;25:10857\u201362. doi: 10.1523\/JNEUROSCI.1738-05.2005 .","journal-title":"J Neurosci"},{"key":"2261_CR12","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/brain\/awr038","volume":"134","author":"MT Fodero-Tavoletti","year":"2011","unstructured":"Fodero-Tavoletti MT, Okamura N, Furumoto S, Mulligan RS, Connor AR, McLean CA, et al. 18F-THK523: a novel in vivo tau imaging ligand for Alzheimer's disease. Brain. 2011;134:1089\u2013100. doi: 10.1093\/Brain\/Awr038 .","journal-title":"Brain"},{"key":"2261_CR13","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","volume":"130","author":"A Lockhart","year":"2007","unstructured":"Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, et al. PIB is a non-specific imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain. 2007;130:2607\u201315. doi: 10.1093\/brain\/awm191 .","journal-title":"Brain"},{"key":"2261_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/WNL.0b013e3181c7da8e","volume":"74","author":"MA Burack","year":"2010","unstructured":"Burack MA, Hartlein J, Flores HP, Taylor-Reinwald L, Perlmutter JS, Cairns NJ. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology. 2010;74:77\u201384. doi: 10.1212\/WNL.0b013e3181c7da8e .","journal-title":"Neurology"},{"key":"2261_CR15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jama.2010.2008","volume":"305","author":"CM Clark","year":"2011","unstructured":"Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA. 2011;305:275\u201383. doi: 10.1001\/jama.2010.2008 .","journal-title":"JAMA"},{"key":"2261_CR16","doi-asserted-by":"crossref","unstructured":"Wong DF, Moghekar AR, Rigamonti D, Brasic JR, Rousset O, Willis W, et al. An in vivo evaluation of cerebral cortical amyloid with [(18)F]Flutemetamol using positron emission tomography compared with parietal biopsy samples in living normal pressure hydrocephalus patients. Mol Imaging Biol. 2012. doi: 10.1007\/s11307-012-0583-x .","DOI":"10.1007\/s11307-012-0583-x"},{"key":"2261_CR17","doi-asserted-by":"crossref","first-page":"10957","DOI":"10.1523\/JNEUROSCI.0673-07.2007","volume":"27","author":"J Maeda","year":"2007","unstructured":"Maeda J, Ji B, Irie T, Tomiyama T, Maruyama M, Okauchi T, et al. Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J Neurosci. 2007;27:10957\u201368. doi: 10.1523\/JNEUROSCI.0673-07.2007 .","journal-title":"J Neurosci"},{"key":"2261_CR18","doi-asserted-by":"crossref","first-page":"e31310","DOI":"10.1371\/journal.pone.0031310","volume":"7","author":"A Manook","year":"2012","unstructured":"Manook A, Yousefi BH, Willuweit A, Platzer S, Reder S, Voss A, et al. Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP\/PS1 mouse model of Alzheimer's disease. PLoS One. 2012;7:e31310. doi: 10.1371\/journal.pone.0031310 .","journal-title":"PLoS One"},{"key":"2261_CR19","doi-asserted-by":"crossref","first-page":"RC189","DOI":"10.1523\/JNEUROSCI.21-24-j0004.2001","volume":"21","author":"ED Agdeppa","year":"2001","unstructured":"Agdeppa ED, Kepe V, Liu J, Flores-Torres S, Satyamurthy N, Petric A, et al. Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer's disease. J Neurosci. 2001;21:RC189.","journal-title":"J Neurosci"},{"key":"2261_CR20","first-page":"1","volume":"19","author":"F Gallyas","year":"1971","unstructured":"Gallyas F. Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morphol Acad Sci Hung. 1971;19:1\u20138.","journal-title":"Acta Morphol Acad Sci Hung"},{"key":"2261_CR21","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1021\/bi0357006","volume":"43","author":"S Barghorn","year":"2004","unstructured":"Barghorn S, Davies P, Mandelkow E. Tau paired helical filaments from Alzheimer's disease brain and assembled in vitro are based on beta-structure in the core domain. Biochemistry. 2004;43:1694\u2013703. doi: 10.1021\/bi0357006 .","journal-title":"Biochemistry"},{"key":"2261_CR22","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1021\/bi052530j","volume":"45","author":"M Bergen von","year":"2006","unstructured":"von Bergen M, Barghorn S, Muller SA, Pickhardt M, Biernat J, Mandelkow EM, et al. The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. Biochemistry. 2006;45:6446\u201357. doi: 10.1021\/bi052530j .","journal-title":"Biochemistry"},{"key":"2261_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2009.06.042","volume":"617","author":"MT Fodero-Tavoletti","year":"2009","unstructured":"Fodero-Tavoletti MT, Mulligan RS, Okamura N, Furumoto S, Rowe CC, Kudo Y, et al. In vitro characterisation of BF227 binding to alpha-synuclein\/Lewy bodies. Eur J Pharmacol. 2009;617:54\u20138. doi: 10.1016\/j.ejphar.2009.06.042 .","journal-title":"Eur J Pharmacol"},{"key":"2261_CR24","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1471-4159.2009.05996.x","volume":"109","author":"PW Thompson","year":"2009","unstructured":"Thompson PW, Ye L, Morgenstern JL, Sue L, Beach TG, Judd DJ, et al. Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies. J Neurochem. 2009;109:623\u201330. doi: 10.1111\/j.1471-4159.2009.05996.x .","journal-title":"J Neurochem"},{"key":"2261_CR25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/BF00293315","volume":"87","author":"E Braak","year":"1994","unstructured":"Braak E, Braak H, Mandelkow EM. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 1994;87:554\u201367.","journal-title":"Acta Neuropathol"},{"key":"2261_CR26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnen\/59.8.733","volume":"59","author":"DR Thal","year":"2000","unstructured":"Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, et al. Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol. 2000;59:733\u201348.","journal-title":"J Neuropathol Exp Neurol"},{"key":"2261_CR27","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/fnl.12.34","volume":"7","author":"VL Villemagne","year":"2012","unstructured":"Villemagne VL, Furumoto S, Fodero-Tavoletti M, Harada R, Mulligan RS, Kudo Y, et al. The challenges of tau imaging. Future Neurol. 2012;7:409\u201321. doi: 10.2217\/fnl.12.34 .","journal-title":"Future Neurol"},{"key":"2261_CR28","doi-asserted-by":"crossref","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","volume":"27","author":"MT Fodero-Tavoletti","year":"2007","unstructured":"Fodero-Tavoletti MT, Smith DP, McLean CA, Adlard PA, Barnham KJ, Foster LE, et al. In vitro characterization of Pittsburgh compound-B binding to Lewy bodies. J Neurosci. 2007;27:10365\u201371. doi: 10.1523\/JNEUROSCI.0630-07.2007 .","journal-title":"J Neurosci"},{"key":"2261_CR29","doi-asserted-by":"crossref","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","volume":"25","author":"WE Klunk","year":"2005","unstructured":"Klunk WE, Lopresti BJ, Ikonomovic MD, Lefterov IM, Koldamova RP, Abrahamson EE, et al. Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J Neurosci. 2005;25:10598\u2013606. doi: 10.1523\/JNEUROSCI.2990-05.2005 .","journal-title":"J Neurosci"},{"key":"2261_CR30","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","volume":"23","author":"WE Klunk","year":"2003","unstructured":"Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L, et al. The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci. 2003;23:2086\u201392.","journal-title":"J Neurosci"},{"key":"2261_CR31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.neuroimage.2008.07.022","volume":"43","author":"J Shin","year":"2008","unstructured":"Shin J, Lee SY, Kim SH, Kim YB, Cho SJ. Multitracer PET imaging of amyloid plaques and neurofibrillary tangles in Alzheimer's disease. Neuroimage. 2008;43:236\u201344. doi: 10.1016\/j.neuroimage.2008.07.022 .","journal-title":"Neuroimage"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-012-2261-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-012-2261-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-012-2261-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T20:17:31Z","timestamp":1562271451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-012-2261-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,26]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["2261"],"URL":"https:\/\/doi.org\/10.1007\/s00259-012-2261-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,26]]}}}